News

University of Bristol research could lead to better detection of the most common type of malignant brain cancer.

The genetic mutation that leads to hereditary hemochromatosis – a condition where the body absorbs too much iron – also causes iron build-up in the brain, increasing the risk of movement disorders.

A team led by biologists at The University of Texas at Arlington has published a study supporting the theory that species that reproduce asexually have more harmful genetic mutations than those utilizing sexual reproduction.

A wearable device has been designed that uses a computer algorithm to measure and interpret mental activity from electrodermal activity in the skin.

Researchers have described the way an enzyme called Polα-primase interacts with proteins to maintain telomeres, the protective caps at the end of chromosomes.

Microbiome-related metabolites like TMAO, as well as blood sugar and general inflammation, appear more important than blood cholesterol or blood pressure in mediating heart disease risk associated with meat intake.

A new human genomics study led by Yale scientists has identified genetic risk factors for opioid use disorder (OUD) and related substance use disorders according to a new large-scale genome-wide association study – increasing the number of risk genes known from 1 to 19.

A new method of delivering an immunotherapy directly to a tumor has been developed, composed of a gelatin/nanoplatelet mixture for effective drug delivery and sustained drug release.

Researchers found a mechanism by which cancers keep T cells from infiltrating tumors by sending out exosome "drones", which offers a new tool to predict how a patient might respond to checkpoint inhibitor drugs.

According to a study, epigenetic changes prevent iron-associated programmed cell death in leukemia and show a new target for treatment with experimental drugs.